Literature DB >> 19825450

Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults.

Stephen J Forman1.   

Abstract

Acute lymphoblastic leukemia (ALL) is a hematologic malignancy of the bone marrow characterized by the rapid proliferation and subsequent accumulation of immature lymphocytes. ALL accounts for 20% of all acute leukemias that are seen in adults over the age of 20 years. In the past 2 decades, there has been substantial improvement in the understanding of the molecular biology of the disease and in the management of adult patients who have this disorder, including allogeneic transplantation This article reviews the biology of adult ALL, the relationship of specific disease characteristics to the natural history of the disease and the role of allogeneic hematopoietic cell transplantation in the management of adult patients with this disease.

Entities:  

Mesh:

Year:  2009        PMID: 19825450     DOI: 10.1016/j.hoc.2009.07.006

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  2 in total

Review 1.  Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults.

Authors:  Eric S Schafer; Stephen P Hunger
Journal:  Nat Rev Clin Oncol       Date:  2011-05-31       Impact factor: 66.675

2.  A Comparison of Dexamethasone Plus Vincristine versus Standard Regimen in Induction Therapy of Adult Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Mohammad Vaezi; Amirhoushang Pourkhani; Amir Kasaeian; Maryam Souri; Marjan Yaghmaie; Bahram Chardouli; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2022-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.